Paladin Advisory Group, LLC Abb Vie Inc. Call Options Transaction History

Paladin Advisory Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $138 - $165	1 Added 0.79%	127 $0
Q3 2022 Oct 07, 2022	BUY	$134.21 - $153.93 $268 - $307	2 Added 1.61%	126 $16,000
Q2 2022 Jul 06, 2022	BUY	$137.62 - $174.96 $275 - $349	2 Added 1.64%	124 $19,000
Q4 2021 Jan 11, 2022	BUY	$107.43 - $135.93 $13,106 - $16,583	122 New	122 $16,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Paladin Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Paladin Advisory Group, LLC with notifications on news.